Eledon Pharmaceuticals
ELDN
ELDN
33 hedge funds and large institutions have $12.7M invested in Eledon Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $14.7M → $12.7M (-$2.02M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $12K
Holders
33
Holding in Top 10
–
Calls
–
Puts
$12K
Top Buyers
| 1 | +$2.74M | |
| 2 | +$2.52M | |
| 3 | +$374K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$69.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$55.5K |
Top Sellers
| 1 | -$2.87M | |
| 2 | -$42.4K | |
| 3 | -$33.2K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$31.6K |
| 5 |
SFG
SVB Financial Group
Dallas,
Texas
|
-$12.2K |